Correlation Between Sonnet Biotherapeutics and Candel Therapeutics
Can any of the company-specific risk be diversified away by investing in both Sonnet Biotherapeutics and Candel Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sonnet Biotherapeutics and Candel Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sonnet Biotherapeutics Holdings and Candel Therapeutics, you can compare the effects of market volatilities on Sonnet Biotherapeutics and Candel Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sonnet Biotherapeutics with a short position of Candel Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sonnet Biotherapeutics and Candel Therapeutics.
Diversification Opportunities for Sonnet Biotherapeutics and Candel Therapeutics
0.88 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Sonnet and Candel is 0.88. Overlapping area represents the amount of risk that can be diversified away by holding Sonnet Biotherapeutics Holding and Candel Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Candel Therapeutics and Sonnet Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sonnet Biotherapeutics Holdings are associated (or correlated) with Candel Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Candel Therapeutics has no effect on the direction of Sonnet Biotherapeutics i.e., Sonnet Biotherapeutics and Candel Therapeutics go up and down completely randomly.
Pair Corralation between Sonnet Biotherapeutics and Candel Therapeutics
Given the investment horizon of 90 days Sonnet Biotherapeutics Holdings is expected to under-perform the Candel Therapeutics. In addition to that, Sonnet Biotherapeutics is 1.11 times more volatile than Candel Therapeutics. It trades about -0.27 of its total potential returns per unit of risk. Candel Therapeutics is currently generating about 0.03 per unit of volatility. If you would invest 465.00 in Candel Therapeutics on September 12, 2024 and sell it today you would lose (4.00) from holding Candel Therapeutics or give up 0.86% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Sonnet Biotherapeutics Holding vs. Candel Therapeutics
Performance |
| Timeline |
| Sonnet Biotherapeutics |
| Candel Therapeutics |
Sonnet Biotherapeutics and Candel Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sonnet Biotherapeutics and Candel Therapeutics
The main advantage of trading using opposite Sonnet Biotherapeutics and Candel Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sonnet Biotherapeutics position performs unexpectedly, Candel Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Candel Therapeutics will offset losses from the drop in Candel Therapeutics' long position.| Sonnet Biotherapeutics vs. Equillium | Sonnet Biotherapeutics vs. DiaMedica Therapeutics | Sonnet Biotherapeutics vs. Valneva SE ADR | Sonnet Biotherapeutics vs. Vivani Medical |
| Candel Therapeutics vs. Aerovate Therapeutics | Candel Therapeutics vs. Adagene | Candel Therapeutics vs. Acrivon Therapeutics, Common | Candel Therapeutics vs. Rezolute |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |